Karen Wrigley, LSW (she/her) is a Social Worker in Norristown, PA with over 16 years of experience. What is your opinion of Karen Wrigley, LSW? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 16 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Karen Wrigley, LSW has received over $11,036 which includes payments from the following companies:
$3,070.04 from Alcon Laboratories Inc
$1,957.70 from OPTOS PLC
$1,508.61 from CooperVision Inc.
$1,247.41 from OPTOS, INC.
$876.07 from Johnson & Johnson Vision Care, Inc.
$645.41 from Bausch & Lomb, a division of Bausch Health US, LLC
$604.68 from Valeant Pharmaceuticals North America LLC
$399.74 from Allergan Inc.
$270.98 from Bausch and Lomb Inc.
$108.99 from OPTOVUE, INC.
$108.91 from TissueTech, Inc.
$62.27 from Shire North American Group Inc
$55.72 from MacuLogix, Inc.
$38.80 from Carl Zeiss Meditec AG
$29.45 from Sun Pharmaceutical Industries Inc.
$18.39 from ABB Con-Cise Optical Group LLC
$17.24 from Carl Zeiss Meditec, Inc.
$16.28 from Menicon America, Inc.
Payments received by Karen Wrigley, LSW were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!
How Social Workers Can Help Patients with Diabetes Get the Best Possible CareSocial workers have a unique role that can facilitate early intervention services to minimize the burden and impact of type II diabetes on individuals of all ages. Diabetes is the third leading cause of death in the United States. Early intervention, ideally immediately after the diagnosis, is an...